Compounds > 2-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4-carboxylic acid
Page last updated: 2024-08-25

2-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4-carboxylic acid and Hepatitis C, Chronic

2-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4-carboxylic acid has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Im, GY; Kazi, S; Perumalswami, PV; Thung, SN1

Other Studies

1 other study(ies) available for 2-(1',2',3',4'-tetrahydroxybutyl)thiazolidine-4-carboxylic acid and Hepatitis C, Chronic

ArticleYear
A maxed-out liver: a case of acute-on-chronic liver failure.
    Seminars in liver disease, 2011, Volume: 31, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Cysteine; Diagnosis, Differential; End Stage Liver Disease; Hepacivirus; Hepatitis C, Chronic; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Thiazolidines

2011